Search

Issue
Title
Authors
The place of antiretroviral therapy in the behavioral strategies aimed at maintaining the health and quality of counseling of people living with HIV
Kozyrina N.V., Belyaeva V.V., Ekaterina S.V., Semikova S.Y., Lebedeva E.P., Gavrilova O.V., Galiullin N.I., Beshimov A.T., Khoraskina E.A., Narkevich A.N., Suvorova Z.K., Khokhlova O.N.
Two-drug antiretroviral therapy regimen with dolutegravir and lamivudine for previously untreated HIV-infected patients
Koshkin A.M., Pokrovskaya A.V.
Human immunodeficiency virus and death
Pokrovsky V.V.
Impact of antiretroviral therapy on the development of the HIV-infection epidemic in the Russian Federation
Sokolova E.V., Ladnaia N.N., Pokrovsky V.V., Kravchenko A.V., Kozyrina N.V., Yurin O.G., Chekryzhova D.G.
Experience with enfuvirtide (fuzeon) in the treatment regimens for HIV infection
Beketova E.V., Bykov S.A.
THE HIV NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS ABACAVIR AND LAMIVUDINE IN FIRST-LINE ANTIRETROVIRAL THERAPY REGIMENS
KRAVCHENKO A.V., KANESTRI V.G.
The spectrum of adverse events in the treatment of multidrug-resistant tuberculosis among people receiving antiretroviral therapy
Degtyareva S.Y., Zimina V.N., Pokrovskaya A.V., Konovalova A.A., Volchenkov G.V.
The first results of using the combined drug rilpivirine/tenofovir/ emtricitabine in Russian patients with HIV infection in real clinical practice
Sizova N.V., Volova L.Y., Malyuzhenko I.V., Isaeva G.N., Koveleno A.Y., Minaeva S.V., Topolskaya S.V., Voronin E.E., Okhonskaya L.V.
DUAL ANTIRETROVIRAL THERAPY WITH LOPINAVIR AND RITONAVIR
Yurin O.G., KRAVCHENKO A.V., KANESTRI V.G., POKROVSKAYA A.V., SHAKHGILDYAN V.I., VOLKOVA S.B.
Combined antiretroviral drugs containing lamivudine and zidovudine for the treatment of HIV infection
Sizova N.V., Korneeva T.S., Bratkova V.V., Sotnikova A.L., Rassokhin V.V.
The efficacy and safety of a new Russian HIV non-nucleoside reverse transcriptase inhibitor (VM-1500, Elpivirine) as a component in an antiretroviral therapy regimen
Kravchenko A.V., Orlova-Morozova E.A., Shimonova T.E., Kozyrev O.A., Nagimova F.I., Bychko V.V., Vostokova N.V., Zozulya O.V.
USE OF A COMBINATION OF THE ANTIRETROVIRAL DRUGS DARUNAVIR ® AND ETRAVIRINE ® IN A PATIENT WITH A RESISTANT HIV STRAIN
MIKOVA O.E., MOISEEVA G.V.
CLINICAL AND LABORATORY FEATURES OF ABNORMALITIES IN THE CERVIX UTERI, EXTERNAL GENITALS, AND VAGINA IN HIV-INFECTED PATIENTS
SUNDUKOV A.V., GAFUROV Y.T., EVSYUKOV O.A.
THE EFFICIENCY OF 48-WEEK TREATMENT WITH LOPINAVIR/RITONAVIR IN COMBINATION WITH LAMIVUDIN IN HIV-1-INFECTED PATIENTS IN THE ROUTINE CLINICAL SETTINGS OF THE RUSSIAN FEDERATION: RESULTS OF A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY (THE SIMPLE STUDY)
Orlova-Morozova E.A., Plotnikova Y.K., Pokrovskaya A.V., Radzikhovskaya M.V., Sizova N.V., Nagimova F.I., Mikhaylov S.P., Wegzyn C.M., Dorr P.K., Potapov A.V., Kruglova A.I.
THE PROBLEM OF BODY WEIGHT GAIN IN HIV-INFECTED PATIENTS DURING ANTIRETROVIRAL THERAPY
KRAVCHENKO A.V., KANESTRI V.G.
The efficacy and safety of Elpivirine as part of a 24-48-week antiretroviral therapy regimen versus an Efavirenz-containing regimen
Kravchenko A.V., Orlova-Morozova E.A., Shimonova T.E., Kozyrev O.A., Nagimova F.I., Zakharova N.G., Ivanova E.S., Sonin D.B., Chernova O.E., Tonkikh O.S., Yakovlev A.A., Kurina N.V., Pokrovsky V.V., Bychko V.V., Vostokova N.V., Zozulya O.V.
Antiretroviral therapy regimens containing the HIV protease inhibitor saquinavir
Kravchenko A.V.
Experience with the HIV protease inhibitor fosamprenavir in first-line antiretroviral therapy regimens in the Chelyabinsk Region
Moskvicheva M.G., Radzikhovskaya M.V.
CLINICOECONOMIC ANALYSIS OF THE USE OF KIVEXA IN THE FIRST-LINE ANTIRETROVIRAL THERAPY OF HIV INFECTION IN THE RUSSIAN FEDERATION
PYADUSHKINA E.A., ANDREEVA N.S., OMELYANOVSKY V.V., AVXENTYEVA M.V., REBROVA O.Y.
Phosphaside and lamivudine as a nucleoside base of first-line antiretroviral therapy regimens for HIV infection
Ivanova E.S.
EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY REGIMENS CONTAINING ETRAVIRINE FOR HIV-INFECTED PATIENTS
KRAVCHENKO A.V., KANESTRI V.G., GANKINA N.Y.
Lipodystrophy syndrome in patients with HIV infection
Khasanova G.R.
USE OF THE FUSION INHIBITOR ENFUVIRTIDE IN ANTIRETROVIRAL THERAPY REGIMENS FOR HIV-INFECTED PATIENTS
Kravchenko A.V., Kanestri V.G.
USE OF A FIXED-DOSE ANTIRETROVIRAL DRUG IN HIV-INFECTED PREGNANT WOMEN
Samarina A.V., Mozaleva O.L., Martirosian M.M., Skryabneva T.S.
Influenza in the HIV infected
Provorova V.V., Krasnova E.I., Khokhlova N.I., Kuimova I.V., Izvekova I.Y.
Results of examination of pregnant women’s sexual partners for HIV infection: The experience of the Sverdlovsk Region
Podymova A.S.
A fixed-dose combination of abacavir/lamivudine as a nucleoside basis for first-line antiretroviral therapy regimens
Konnov V.V., Kozyreva N.V., Kanestri V.G., Narsia R.S., Yurin O.G.
THE NOVEL HIV NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR RILPIVIRINE: A REVIEW OF INTERNATIONAL CLINICAL TRIALS
KANESTRI V.G.
Studying the transmission of HIV-1 drug resistance in the Republic of Armenia using bioinformatics methods
Osadchaya O.A., Eroshkin P.V., Kirichenko A.A., Lapovok I.A., Saleeva D.V., Lopatukhin A.E., Shlykova A.V., Kireev D.E., Grigoryan T.R., Petrosyan A.R., Sarhatyan T.A., Pokrovsky V.V.
ATAZANAVIR IN BASIC ANTIRETROVIRAL THERAPY REGIMENS: A REVIEW OF CONVINCING DATA
MAKSIMOV S.L.
Use of non-boosted atazanavir in clinical practice
Kanestri V.G., Yagodkin M.V.
Hepatotoxicity of antiretroviral therapy in HIV-infected patients
Kanestri V.G., Kravchenko A.V., Gankina N.Y.
CONTRIBUTION OF A FIXED-DOSE ABACAVIR/LAMIVUDINE COMBINATION TO IMPROVING TREATMENT COMPLIANCE IN HIV-INFECTED PATIENTS
KANESTRI V.G.
COST-MINIMIZATION ANALYSIS OF ETRAVIRINE AND RALTEGRAVIR USED IN THERAPY FOR HIV INFECTION
BELOUSOV Y.B., AFANASYEVA E.V., BELOUSOV D.Y., BEKETOV A.S.
The use of doravirme as part of antiretroviral therapy regimens in patients with resistance mutations
Orlova-Morozova E.A., Pronin A.Y.
A cascade model in the evaluation of the efficiency of healthcare for HIV-positive people
Pokrovskaya A.V., Ladnaya N.N., Yurin O.G., Dementieva L.A., Pokrovsky V.V.
PROSPECTS FOR THE LONG-TERM EFFICACY OF FOSAMPRENAVIR (TELZIR) USED AS PART OF ANTIRETROVIRAL THERAPY IN HIV-INFECTED PATIENTS
GUSHCHINA Y.S., KUVAEVA M.B.
HIV-1 drug resistance in patients with virological inefficiency on ART in Russia in 2013-2021
Kirichenko A.A., Kireev D.E., Shlykova A.V., Lopatukhin A.E., Lapovok I.A., Saleeva D.V., Kravchenko A.V., Pokrovsky V.V.
MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME DURING ANTIRETROVIRAL THERAPY IN PATIENTS WITH HIV INFECTION
KRAVCHENKO A.V., ZIMINA V.N., VIKTOROVA I.B., SITDYKOVA Y.R.
HIV drug resistance: Dolutegravir is a second-generation HIV integrase inhibitor
Kravchenko A.V., Kanestri V.G.
CLINICOECONOMIC ANALYSIS OF THE USE OF MARAVIROC VERSUS OTHER RESERVE DRUGS IN PATIENTS WHO HAVE EXPERIENCED ANTIRETROVIRAL THERAPY FOR HIV INFECTION
PYADUSHKINA E.A., GORYAYNOV S.V., OMELYANOVSKY V.V., AVXENTYEVA M.V., REBROVA O.Y.
The demographic and clinical characteristics of HIV-infected women in routine clinical practice in the Russian Federation: Results of a multicenter crosssectional non-interventional study
Voronin E.E., Afonina L.Y., Orlova-Morozova E.A., Plotnikova Y.K., Radzikhovskaya M.V.
A virologic response as a hallmark of excellence: TDF/FTC or TDF/3TC
Kozyrina N.V., Yurin O.G.
ABAKAVIR I LAMIVUDIN KAK NUKLEOZIDNAYa OSNOVA ANTIRETROVIRUSNOY TERAPII
KOZYRINA N.V., NARSIA R.S., YURIN O.G.
EXPERIENCE WITH THE HIV PROTEASE INHIBITOR FOSAMPRENAVIR IN RUSSIAN PRACTICE
VOLKOVA S.B., PODYMOVA A.S.
1 - 45 of 45 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies